LY466195, a clinically active compound in the acute treatment of migraine, inhibits activation in the trigeminocervical complex and the ventroposteromedial thalamus after nociceptive trigeminovascular activation

A. P. Andreou; P. J. Goadsby

LY466195, a clinically active compound in the acute treatment of migraine, inhibits activation in the trigeminocervical complex and the ventroposteromedial thalamus after nociceptive trigeminovascular activation

Research output: Contribution to journal › Poster abstract › peer-review

Original language	English
Pages (from-to)	132-132
Number of pages	1
Journal	Cephalalgia
Volume	29
Publication status	Published - Oct 2009

Cite this

@article{7496bf81ef8b4d04bd18328f4679088e,

title = "LY466195, a clinically active compound in the acute treatment of migraine, inhibits activation in the trigeminocervical complex and the ventroposteromedial thalamus after nociceptive trigeminovascular activation",

author = "Andreou, {A. P.} and Goadsby, {P. J.}",

year = "2009",

month = oct,

language = "English",

volume = "29",

pages = "132--132",

journal = "Cephalalgia",

issn = "0333-1024",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - LY466195, a clinically active compound in the acute treatment of migraine, inhibits activation in the trigeminocervical complex and the ventroposteromedial thalamus after nociceptive trigeminovascular activation

AU - Andreou, A. P.

AU - Goadsby, P. J.

PY - 2009/10

Y1 - 2009/10

M3 - Poster abstract

SN - 0333-1024

VL - 29

SP - 132

EP - 132

JO - Cephalalgia

JF - Cephalalgia

ER -